Christopher Saca has extensive experience in the pharmaceutical industry, currently serving as Senior Director of Market Access and Value at Gilead Sciences since January 2010. Prior to this role, Christopher held the position of Director at Schering Pharmaceuticals from June 1999 to January 2010, where responsibilities included engaging with therapeutic specialties. Christopher holds a Master of Business Administration with a focus on International Business from Pepperdine Graziadio Business School and a Bachelor of Science in Biology from UC Irvine's Charlie Dunlop School of Biological Sciences.
This person is not in any teams
This person is not in any offices